[AsCNP_O5] Oral Session 5
Schizophrenia

[AsCNP-O5-1] Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey

^○Shunya KUROKAWA¹, Taishiro KISHIMOTO^{1, 2}, Kuan-pin SU³, Jane Pei-Chen CHANG³, Hui-Chih CHANG³, Xin YU⁴, Nuno RODRIGUES-SILVA⁵, Jimmi NIELSEN⁶, Anish UNADKAT⁷, David CASTLE⁷, Peter M. HADDAD⁸, Deyvis ROCHA⁹, Ary GADELHA⁹, Styliani KALIORA², Georgios PETERIDES², Ofer AGID¹⁰, Yuki TAZAWA¹, Akihiro TAKAMIYA¹, Toshiro HORIGOME¹, John KANE² (1. Department of Psychiatry, Keio University School of Medicine, Tokyo, Japan, 2. Department of Psychiatry, The Zucker Hillside Hospital, New York, 3. Department of Psychiatry & Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan, 4. Peking University Institute of Mental Health (Sixth Hospital), Beijing, 5. Department of Psychiatry and Mental Health, Cova da Beira University Healthcare Center, Covilhã, Portugal, 6. Mental health Centre Glostrup, Copenhagen University Hospital, Copenhagen, Denmark, 7. The University of Melbourne and St Vincent’s Hospital Melbourne, Australia, 8. Department of Psychiatry, University of Manchester, Manchester, UK, 9. Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil, 10. Schizophrenia Program, Centre for Addiction and Mental Health, Department of Psychiatry, Faculty of Medicine, University of Toronto, Canada)